1. Home
  2. MSEX vs TBPH Comparison

MSEX vs TBPH Comparison

Compare MSEX & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Middlesex Water Company

MSEX

Middlesex Water Company

HOLD

Current Price

$52.28

Market Cap

998.7M

Sector

Utilities

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$20.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSEX
TBPH
Founded
1897
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
998.7M
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MSEX
TBPH
Price
$52.28
$20.31
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$60.33
$27.80
AVG Volume (30 Days)
100.1K
379.1K
Earning Date
02-27-2026
02-25-2026
Dividend Yield
2.75%
N/A
EPS Growth
3.71
N/A
EPS
2.39
0.58
Revenue
$194,822,000.00
$80,327,000.00
Revenue This Year
$4.02
$70.78
Revenue Next Year
$8.35
N/A
P/E Ratio
$21.92
$34.88
Revenue Growth
6.24
27.12
52 Week Low
$44.17
$7.90
52 Week High
$67.09
$21.03

Technical Indicators

Market Signals
Indicator
MSEX
TBPH
Relative Strength Index (RSI) 48.97 60.45
Support Level $52.85 $19.53
Resistance Level $53.98 $21.03
Average True Range (ATR) 1.24 0.83
MACD 0.13 0.07
Stochastic Oscillator 44.92 76.45

Price Performance

Historical Comparison
MSEX
TBPH

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: